ClinicalTrials.gov
ClinicalTrials.gov Menu

Study of Rivaroxaban Use and Potential Adverse Outcomes in Routine Clinical Pratice (UK)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT01947998
Recruitment Status : Recruiting
First Posted : September 23, 2013
Last Update Posted : June 12, 2018
Sponsor:
Collaborator:
Janssen Research & Development, LLC
Information provided by (Responsible Party):
Bayer

No Study Results Posted on ClinicalTrials.gov for this Study
  Recruitment Status : Recruiting
  Estimated Primary Completion Date : December 31, 2018
  Estimated Study Completion Date : December 31, 2019